Advertisement
Screener

ACLARION, INC. (ACON) Form D

ACLARION, INC. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2024-10-15: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2024-09-30; Total offering amount $1,000,000.
  • 2023-05-31: Federal exemption Rule 506(b); Types of securities offered Equity; Debt; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2023-05-16; Total offering amount $2,000,000.
  • 2021-10-26: Federal exemption Rule 506(b); Types of securities offered Debt; SecurityToBeAcquired; Date of first sale 2021-06-17; Total offering amount $2,000,000.
  • 2020-03-12: Federal exemption Rule 506(b); Types of securities offered Debt; OptionToAcquire; Date of first sale 2020-02-27; Total offering amount $2,500,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2024-10-15Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2024-09-30$1,000,000$1,000,000$03
2023-05-31Rule 506(b)Equity; Debt; OptionToAcquire; SecurityToBeAcquired2023-05-16$2,000,000$2,000,000$02
2021-10-26Rule 506(b)Debt; SecurityToBeAcquired2021-06-17$2,000,000$2,000,000$04
2020-03-12Rule 506(b)Debt; OptionToAcquire2020-02-27$2,500,000$1,402,965$1,097,03512

Similar stocks

Stock NameCountryMarket CapPE Ratio
Advanced Biomed Inc. (ADVB)$0.009B
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64
BioNexus Gene Lab Corp (BGLC)$0.004B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
Freenome, Inc. (FRNM)United States$0.143B
EXAGEN INC. (XGN)United States$0.212B-5.95
BIODESIX INC (BDSX)United States$0.312B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45